Ziarco is an independent, clinical stage biotechnology company progressing novel & differentiated therapies for inflammatory and allergic diseases, using both oral and topical routes of delivery. Ziarco has 4 major development programmes staffed by highly experienced drug development professionals.
Funding Rounds (2) - $8.9MUpdate
We are a private equity investment company that invests financial and intellectual capital in...
Biotechnology Value Fund, L.P. is an evergreen fund specializing in early stage financing. It...
Pfizer Venture Investments (PVI) serves as the venture capital arm of Pfizer, supporting a...
12-17 Upper Bridge Street, Offices 205-6, Canterbury
Kent, CT1 2NF